Variant report
Variant | nsv1031976 |
---|---|
Chromosome Location | chr8:112556471-112591382 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4876699 | chr8:112556471-112556472 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs570678974 | chr8:112556489-112556490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539778840 | chr8:112556497-112556498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138463038 | chr8:112556529-112556530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572121294 | chr8:112556542-112556543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4876700 | chr8:112556564-112556565 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs541433178 | chr8:112556594-112556595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs16882142 | chr8:112556606-112556607 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs544128147 | chr8:112556610-112556611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs115969349 | chr8:112556644-112556645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146049601 | chr8:112556652-112556653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs367580097 | chr8:112556654-112556655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2217375 | chr8:112556687-112556688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35065390 | chr8:112556698-112556699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564159086 | chr8:112556699-112556700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376459196 | chr8:112556723-112556724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563577386 | chr8:112556824-112556825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563568902 | chr8:112556835-112556836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529163590 | chr8:112556841-112556842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11782719 | chr8:112556843-112556844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200597170 | chr8:112556853-112556854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs3028839 | chr8:112556882-112556883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs62520418 | chr8:112556969-112556970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548297040 | chr8:112557008-112557009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568416805 | chr8:112557021-112557022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149260867 | chr8:112557022-112557023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547855648 | chr8:112557058-112557059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs16882144 | chr8:112557072-112557073 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs370651187 | chr8:112557095-112557096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559315127 | chr8:112557096-112557097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183070934 | chr8:112557098-112557099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35892814 | chr8:112557116-112557117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs71923512 | chr8:112557118-112557119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539642922 | chr8:112557120-112557121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556297732 | chr8:112557167-112557168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570016485 | chr8:112557168-112557169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs996641 | chr8:112557211-112557212 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs555082535 | chr8:112557215-112557216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571990746 | chr8:112557287-112557288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540794701 | chr8:112557312-112557313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186345846 | chr8:112557409-112557410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs11997164 | chr8:112557452-112557453 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs146941375 | chr8:112557454-112557455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs11990106 | chr8:112557497-112557498 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs75718304 | chr8:112557515-112557516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs137905033 | chr8:112557557-112557558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs78756577 | chr8:112557565-112557566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs561974876 | chr8:112557571-112557572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144125139 | chr8:112557576-112557577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs547623305 | chr8:112557580-112557581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:112552800-112557800 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr8:112557200-112558800 | Enhancers | Fetal Lung | lung |
3 | chr8:112557800-112558400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr8:112557800-112558600 | Strong transcription | Adipose Nuclei | Adipose |
5 | chr8:112558600-112560200 | Weak transcription | Adipose Nuclei | Adipose |
6 | chr8:112575200-112577600 | Enhancers | Liver | Liver |
7 | chr8:112575800-112578400 | Enhancers | HepG2 | liver |
8 | chr8:112578200-112578400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |